SUBSTITUEREDE AZOANTHRACENDERIVATER, FARMACEUTISKE SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL ANVENDELSE HERAF

The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, d...

Full description

Saved in:
Bibliographic Details
Main Authors YARRAGUNTA, RAVINDRA REDDY, DAVIS, STEPHEN THOMAS, BEHME, CHRISTOPHER, GOHIMUKKULA, DEVI REDDY, SANTHOSH, KALPATHY, BONDLELA, MURALIDHAR, GUZEL, MUSTAFA, CHRISTEN, DANIEL P, POLISETTI, DHARMA RAO, FREEMAN, JENNIFER, L.R, QUADA, JAMES, YOKUM, THOMAS SCOTT, MJALLI, ADNAN M.M, ANDREWS, ROBERT CARL
Format Patent
LanguageDanish
Published 16.11.2015
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
CHEMISTRY
FISHING
FORESTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HUNTING
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEST REPELLANTS OR ATTRACTANTS
PLANT GROWTH REGULATORS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TRAPPING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.
Bibliography:Application Number: DK20100779665T